Tocilizumab for Acute Chest Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease · Acute Chest Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Austin Wesevich, MD) · austin.wesevich@uchicagomedicine.org · 773-834-6732

Study leads

Austin Wesevich, MD
Principal Investigator
University of Chicago

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Sickle Cell Disease · Sickle Cell Anemia · Osteonecrosis

Abroad (travel likely)RecruitingPHASE2

Sacramento, United States

Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study

Sickle Cell Disease · Sickle Cell Anemia in Children

Abroad (travel likely)RecruitingPHASE1, PHASE2

Kampala, Uganda

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Sickle Cell Disease · Thalassemia, Beta · Thalassemia

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Severe Sickle Cell Disease · Bone Marrow Failure Syndromes · Metabolic Disorders

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Wilmington, United States